We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+8.54%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$446B
AUM Growth
+$49.9B
Cap. Flow
+$20.1B
Cap. Flow %
4.51%
Top 10 Hldgs %
17.27%
Holding
6,869
New
821
Increased
2,556
Reduced
2,333
Closed
700

Sector Composition

Rank Sector Weight
1 Technology 14.59%
2 Consumer Discretionary 9.73%
3 Financials 8.55%
4 Healthcare 8.03%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSTA icon
5876
Lisata Therapeutics
LSTA
$9.02M
$87K ﹤0.01%
+3,592
New +$85.1K
VPCBW
5877
DELISTED
VPC Impact Acquisition Holdings II Warrant
VPCBW
$87K ﹤0.01%
+75,741
New +$72.8K
TMAC.WS
5878
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$87K ﹤0.01%
102,862
-31,512
-23% -$21.4K
GNPX icon
5879
Genprex
GNPX
$3.02M
$86K ﹤0.01%
+1
New +$164K
LYRA
5880
DELISTED
LYRA THERAPEUTICS INC
LYRA
$86K ﹤0.01%
215
-4
-2% -$1.82K
CTHR
5881
DELISTED
Charles & Colvard Ltd
CTHR
$86K ﹤0.01%
+2,894
New +$83.4K
WMC
5882
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$86K ﹤0.01%
2,633
-1,511
-36% -$50.1K
IRON icon
5883
Disc Medicine
IRON
$2.94B
$85K ﹤0.01%
436
-879
-67% -$289K
NSPR icon
5884
InspireMD
NSPR
$30.4M
$85K ﹤0.01%
+16,832
New +$102K
HHLA.WS
5885
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$85K ﹤0.01%
97,500
HALL
5886
DELISTED
Hallmark Financial Services, Inc.
HALL
$84K ﹤0.01%
1,885
-2,007
-52% -$83.7K
ELVN icon
5887
Enliven Therapeutics
ELVN
$3.92B
$83K ﹤0.01%
2,637
-549
-17% -$17K
IPVF.WS
5888
DELISTED
InterPrivate III Financial Partners Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
IPVF.WS
$83K ﹤0.01%
+72,949
New +$71.2K
OIIM
5889
DELISTED
02Micro International
OIIM
$83K ﹤0.01%
11,569
-20,748
-64% -$150K
TYME
5890
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$83K ﹤0.01%
66,076
+3,681
+6% +$5.31K
CLSD
5891
DELISTED
Clearside Biomedical
CLSD
$82K ﹤0.01%
+1,118
New +$52K
PVLA
5892
Palvella Therapeutics
PVLA
$1.99B
$82K ﹤0.01%
266
-2,699
-91% -$592K
SCPX
5893
DELISTED
Scorpius Holdings, Inc.
SCPX
$82K ﹤0.01%
3
GBRGR
5894
DELISTED
Goldenbridge Acquisition Limited Right
GBRGR
$82K ﹤0.01%
+217,348
New +$83.1K
PACXW
5895
DELISTED
Pioneer Merger Corp. Warrant
PACXW
$82K ﹤0.01%
+51,225
New +$59.5K
VELOW
5896
DELISTED
Velocity Acquisition Corp. Warrant
VELOW
$82K ﹤0.01%
+92,665
New +$69.7K
ALTIW
5897
DELISTED
AlTi Global Inc Warrant
ALTIW
$81K ﹤0.01%
+97,096
New +$66.3K
SREV
5898
DELISTED
ServiceSource International, Inc.
SREV
$81K ﹤0.01%
57,457
-52,143
-48% -$68.6K
HBP
5899
DELISTED
Huttig Building Products, Inc.
HBP
$81K ﹤0.01%
+14,056
New +$74.3K
BTBT icon
5900
Bit Digital
BTBT
$463M
$79K ﹤0.01%
+11,622
New +$124K

Similar funds

Goldman Sachs's Q2 2021 Portfolio in Review

As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.

  • Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
  • Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
  • Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
  • Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
  • Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
  • Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
  • Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.